rs830994

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_004525.3(LRP2):​c.2025C>T​(p.Val675Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.647 in 1,613,364 control chromosomes in the GnomAD database, including 341,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 29403 hom., cov: 33)
Exomes 𝑓: 0.65 ( 312379 hom. )

Consequence

LRP2
NM_004525.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.0940

Publications

33 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 2-169273018-G-A is Benign according to our data. Variant chr2-169273018-G-A is described in ClinVar as Benign. ClinVar VariationId is 129507.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.094 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.2025C>T p.Val675Val synonymous_variant Exon 15 of 79 ENST00000649046.1 NP_004516.2
LRP2XM_011511183.4 linkc.2025C>T p.Val675Val synonymous_variant Exon 15 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.1101C>T p.Val367Val synonymous_variant Exon 15 of 79 XP_047300296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.2025C>T p.Val675Val synonymous_variant Exon 15 of 79 NM_004525.3 ENSP00000496870.1
LRP2ENST00000443831.1 linkc.1818C>T p.Val606Val synonymous_variant Exon 14 of 23 2 ENSP00000409813.1
LRP2ENST00000493501.1 linkn.368C>T non_coding_transcript_exon_variant Exon 2 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.615
AC:
93399
AN:
151888
Hom.:
29400
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.519
Gnomad AMI
AF:
0.686
Gnomad AMR
AF:
0.541
Gnomad ASJ
AF:
0.701
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.515
Gnomad FIN
AF:
0.665
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.661
Gnomad OTH
AF:
0.657
GnomAD2 exomes
AF:
0.628
AC:
157447
AN:
250798
AF XY:
0.628
show subpopulations
Gnomad AFR exome
AF:
0.517
Gnomad AMR exome
AF:
0.480
Gnomad ASJ exome
AF:
0.708
Gnomad EAS exome
AF:
0.917
Gnomad FIN exome
AF:
0.669
Gnomad NFE exome
AF:
0.659
Gnomad OTH exome
AF:
0.648
GnomAD4 exome
AF:
0.650
AC:
949919
AN:
1461358
Hom.:
312379
Cov.:
54
AF XY:
0.647
AC XY:
470252
AN XY:
727002
show subpopulations
African (AFR)
AF:
0.526
AC:
17596
AN:
33442
American (AMR)
AF:
0.491
AC:
21898
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
18445
AN:
26118
East Asian (EAS)
AF:
0.858
AC:
34042
AN:
39696
South Asian (SAS)
AF:
0.506
AC:
43666
AN:
86250
European-Finnish (FIN)
AF:
0.672
AC:
35923
AN:
53420
Middle Eastern (MID)
AF:
0.721
AC:
4150
AN:
5758
European-Non Finnish (NFE)
AF:
0.661
AC:
734715
AN:
1111670
Other (OTH)
AF:
0.654
AC:
39484
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
19861
39722
59583
79444
99305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19102
38204
57306
76408
95510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.615
AC:
93432
AN:
152006
Hom.:
29403
Cov.:
33
AF XY:
0.611
AC XY:
45415
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.519
AC:
21494
AN:
41452
American (AMR)
AF:
0.541
AC:
8257
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.701
AC:
2433
AN:
3472
East Asian (EAS)
AF:
0.900
AC:
4648
AN:
5166
South Asian (SAS)
AF:
0.514
AC:
2476
AN:
4814
European-Finnish (FIN)
AF:
0.665
AC:
7027
AN:
10572
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.661
AC:
44892
AN:
67952
Other (OTH)
AF:
0.655
AC:
1381
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1823
3646
5469
7292
9115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.639
Hom.:
41893
Bravo
AF:
0.611
Asia WGS
AF:
0.649
AC:
2256
AN:
3476
EpiCase
AF:
0.677
EpiControl
AF:
0.682

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Donnai-Barrow syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
5.8
DANN
Benign
0.72
PhyloP100
0.094
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs830994; hg19: chr2-170129528; COSMIC: COSV107231800; API